Mira Pharmaceuticals Faces Delisting Concerns
Ticker: MIRA · Form: 8-K · Filed: Apr 11, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, pharmaceuticals
TL;DR
Mira Pharma might get delisted, big trouble ahead.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on April 11, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Mira1a Therapeutics, Inc., was incorporated in Florida and has its principal executive offices in Miami. The filing indicates a potential issue with its continued listing on a stock exchange.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could significantly impact the company's stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on major exchanges, posing a severe risk to its operations and shareholder value.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former Company Name
- April 8, 2025 (date) — Date of Report
- April 11, 2025 (date) — Filing Date
- Florida (location) — State of Incorporation
- Miami (location) — Principal Executive Offices City
FAQ
What specific rule or standard has Mira Pharmaceuticals failed to satisfy that led to this notice of delisting?
The filing does not specify the exact rule or standard that Mira Pharmaceuticals has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was Mira Pharmaceuticals, Inc. formerly known as Mira1a Therapeutics, Inc.?
The company's name was changed from Mira1a Therapeutics, Inc. on January 12, 2022.
What is the primary business of Mira Pharmaceuticals, Inc. according to its SIC code?
Mira Pharmaceuticals, Inc. is classified under Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
Where are Mira Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices of Mira Pharmaceuticals, Inc. are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the Commission File Number for Mira Pharmaceuticals, Inc.?
The Commission File Number for Mira Pharmaceuticals, Inc. is 001-41765.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).